S-1/A: SHF Holdings Files S-1/A for 22.6M Share Resale

SHF Holdings, Inc. has filed an S-1/A amendment to register up to 22,598,184 shares of Class A Common Stock for resale by selling stockholders.

Summary

• SHF Holdings, Inc. (SHF) has filed an S-1/A amendment to register for resale up to 22,598,184 shares of its Class A Common Stock.
• These shares represent those underlying Series B Warrants, shares issued to Partner Colorado Credit Union (PCCU), and shares received by PCCU in a De-SPAC transaction.
• The company is not selling any securities in this offering and will not receive proceeds, except for potential exercise prices of Series B Warrants, estimated at $15.5 million if all are exercised for cash.
• SHF is an emerging growth company and a smaller reporting company, subject to reduced reporting requirements.
• The company's common stock is listed on Nasdaq under the symbol SHFS, with a recent closing price of $0.44 per share as of June 3, 2026.
• SHF faces risks related to Nasdaq listing compliance, including a minimum bid price requirement of $1.00 per share, and potential delisting if compliance is not regained by October 19, 2026.
• The company has identified material weaknesses in internal controls related to loan documentation and credit loss estimation processes.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to significant going concern risks, Nasdaq delisting threats, and identified material weaknesses in internal controls, despite some positive strategic developments.

Positives

• The company has a proprietary technology platform operating across 41 states and territories.
• SHF has a decade of experience navigating cannabis banking regulations and has passed numerous audits.
• The company has established relationships with CRBs and financial institutions.
• The September 2025 Recapitalization eliminated approximately $18 million in debt and raised over $6.7 million in new capital.
• An Equity Line of Credit (ELOC) of $150 million, potentially expandable to $500 million, has been established.
• The Second Amended CAA increases SHF's share of loan program income to up to 65%.

Negatives

• The company has incurred recurring operating losses and negative cash flows from operations, raising substantial doubt about its ability to continue as a going concern.
• SHF received a Nasdaq deficiency letter on April 22, 2026, for failing to maintain a minimum closing bid price of $1.00 per share, with a compliance deadline of October 19, 2026.
• A material weakness in internal control over financial reporting related to loan documentation and credit loss estimation processes has been identified.
• Revenue has declined due to account attrition, lower pricing, and reduced transaction activity within the cannabis industry.
• The company's investment in ADTX preferred securities is illiquid and subject to impairment.
• The company's business is highly concentrated with PCCU, which accounts for a significant majority of its revenue.

Risks

• The company's profitability is subject to interest rate risk and volatility in financial markets.
• The cannabis industry operates in a federally illegal environment, posing risks if federal enforcement policies change.
• The company's strategic plan and growth strategy may not be achieved as quickly or fully as sought.
• Potential gaps in risk management policies could expose the company to unidentified or unanticipated risks.
• The company is dependent on third-party vendors for critical services, and system failures could impact operations.
• Failure to protect customer information could adversely affect reputation and lead to financial sanctions.
• Future acquisitions and expansion activities may disrupt business, dilute shareholder value, and adversely affect operating results.
• The company may be unable to generate sufficient cash to service its operational needs.
• The company is subject to extensive regulations that could limit its activities and adversely affect earnings.
• Litigation and regulatory investigations are common and may result in significant financial losses.
• Liquidity risks arise from uncertainty surrounding cash flows.
• The company is subject to capital adequacy and Nasdaq liquidity standards.
• Certain existing stockholders could exert significant control over the company.
• If securities or industry analysts do not publish research or publish inaccurate research, the stock price and trading volume could decline.
• The company has the ability to issue additional equity securities, which would lead to dilution.
• The company may be unable to attract and retain key personnel.
• In certain circumstances, the company assumes the risk of fraud loss and negative balances for accounts maintained at its financial institution partners.
• Severe weather, natural disasters, global pandemics, acts of war or terrorism, theft, civil unrest, government expropriation or other external events could have significant effects on the business.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company's ability to comply with Nasdaq's listing requirements and maintain its listing is uncertain.
• The company's Series B Preferred Stock and Series B Warrants contain anti-dilution and reset provisions that could further dilute common stockholders.
• The company's common stock price may be highly volatile, and stockholders may not be able to sell their shares at or above their purchase price.
• The soundness of the company's financial institution customers and partners could adversely affect it.
• The company's investment in ADTX preferred securities is illiquid, subject to impairment, and may result in a partial or total loss.
• The Second Amended CAA introduces significant new accounting complexity involving material judgment and estimation uncertainty.
• The company has identified a material weakness in internal control over financial reporting related to its loan documentation and expected credit loss estimation process.
• An adverse outcome in litigation could materially and adversely affect the company.
• Changes in laws, regulations, or rules applicable to cannabis banking, financial services, or public company reporting could adversely affect the business and results of operations.
• An interruption in, or breach of security of, the company's information systems could adversely affect it.
• The company may suffer uninsured losses or losses in excess of its insurance limits.
• Recent developments in shareholder litigation against the company on certain counterclaims could result in a material adverse effect on its financial position, results of operations, and cash flows.
• There can be no assurance that the company will be able to comply with the continued listing standards of Nasdaq.
• The market for the company's securities has been volatile and may continue to be volatile, which would adversely affect the liquidity and price of its securities.
• The company may issue additional shares of common or preferred stock under the Equity Incentive Plan or otherwise, any one of which would dilute the interest of the company's stockholders and likely present other risks.
• The company's operating results may fluctuate significantly and could fall below the expectations of securities analysts and investors due to seasonality and other factors, some of which are beyond its control, resulting in a decline in its stock price.
• If securities or industry analysts do not publish or cease publishing research or reports about the Company, its business, or its market, or if they change their recommendations regarding its Common Stock adversely, then the price and trading volume of the Common Stock could decline.
• The company may be unable to obtain additional financing to fund its operations and growth.
• Anti-takeover provisions contained in its Second Amended and Restated Certificate of Incorporation and Bylaws, as well as provisions of Delaware law, could impair a takeover attempt, which could limit the price investors might be willing to pay in the future for its Common Stock.
• The company's Second Amended and Restated Certificate of Incorporation provides that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for certain stockholder litigation matters, which could limit its stockholders ability to obtain a favorable judicial forum for disputes with the company or its directors, officers, employees or stockholders.
• The JOBS Act permits emerging growth companies like the company to take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies.
• The Certificate of Designation governing its Series B Preferred Stock contains covenants that may limit its business flexibility.

Future Outlook

The company aims to stabilize and organically grow its core platform business, deepen lending-related revenue through the Second Amended CAA and expanding capital partnerships, build complementary service lines, maintain and expand financial institution partnerships, and position itself to benefit from anticipated favorable changes in the federal cannabis banking regulatory environment. Management is focused on improving client retention through expanded lending capabilities and enhanced client service technology.

Management Comments

• Management believes that the combination of its established compliance and banking infrastructure, expanded on-site review capabilities, emerging managed services business, and growing network of capital and strategic partnerships positions it to serve cannabis businesses and financial institutions more comprehensively than any other provider in its market.
• Management believes that a potential rescheduling of cannabis could materially improve operator cash flows and profitability.
• Management believes that passage of the SAFER Banking Act or related federal cannabis banking legislation, or regulatory relief related to the rescheduling of cannabis to Schedule III, would meaningfully lower the barrier to entry for financial institutions and expand the scope of institutions willing to enter the cannabis banking market.

Industry Context

StockSavvy.ai notes that the U.S. cannabis market is substantial and growing, but faces significant challenges due to the federal illegality of cannabis. Regulatory developments, such as potential rescheduling to Schedule III and the SAFER Banking Act, are key factors influencing the industry's future. SHF Holdings operates in this complex environment, providing essential compliance and financial services to cannabis-related businesses.

Comparison to Industry Standards

• The U.S. state-licensed cannabis market revenues were estimated at approximately $30.4 billion in 2025, with projections to exceed $76 billion by 2030.
• Approximately 998 depository institutions (816 banks and 182 credit unions) were actively filing marijuana-related SARs as of December 2024, representing less than 11% of U.S. depository institutions.
• Industry analysts estimate that less than 200 financial institutions nationwide have a dedicated, actively marketed cannabis banking program.
• Cannabis businesses collectively carry an estimated $2.5 billion in debt, and only about 27% were profitable in 2024, compared to 42% in 2022.

Management Changes

Legal Proceedings

• SHF Holdings, Inc. v. Daniel Roda, Gregory W. Ellis, and James R. Carroll (Denver County District Court, Case No. 2024CV33187) concerning the validity of the Second Amendment to the Abaca Merger Agreement. The court denied SHF's motion for summary judgment and granted summary judgment in favor of counterclaim plaintiffs on the validity of the Second Amendment and breach of the original Merger Agreement regarding first anniversary parent shares. Damages are to be determined at a future hearing.
• The company has a potential loss range of $0 to $7.8 million related to the Abaca litigation, with no accrual recorded beyond the $3.0 million deposited in court registry.

Related Party Transactions

• SHF's business is heavily concentrated with Partner Colorado Credit Union (PCCU), which is a significant stockholder, the primary financial institution partner, and holds the majority of SHF's cash deposits.
• Revenue generated from PCCU approximated 86.7% of total revenue for the year ended December 31, 2025.
• Amounts due from PCCU represented 97.0% of total accounts receivable as of December 31, 2025.
• On September 30, 2025, PCCU cancelled SHF's outstanding Senior Secured Promissory Note of approximately $10.7 million in exchange for Series B Convertible Preferred Stock and Series B Warrants.

Stakeholder Impact

• Shareholders face potential dilution from the conversion of Series B Preferred Stock, exercise of Series B Warrants, and future draws under the ELOC.
• Shareholders may experience volatility in the stock price and difficulty selling shares at or above their purchase price.
• A delisting from Nasdaq would materially impair the company's ability to make future draws under the ELOC and adversely affect stockholders' ability to trade shares.
• The company's ability to fund any potential litigation payments may be materially constrained by the terms of the ELOC or Series B Preferred Stock.

Next Steps

• Regain compliance with Nasdaq's minimum bid price requirement by October 19, 2026.
• Continue to implement remediation plans for identified material weaknesses in internal controls.
• Actively monitor the bid price of its common stock and evaluate options to resolve the deficiency.
• Potentially draw on the ELOC to fund operations and growth.
• Seek to expand its financial institution partner base to reduce revenue concentration.

Key Dates

Recommendation

While the company has strategic initiatives and a strong market position in cannabis banking, the significant going concern risks, Nasdaq delisting threats, and identified material weaknesses in internal controls warrant a cautious approach. The potential for dilution and the ongoing litigation also present considerable downside risk. A 'hold' recommendation reflects the balance between potential upside from industry trends and the substantial near-term risks.

Keywords

SHF Holdings, S-1/A, Common Stock, Resale Registration, Series B Warrants, PCCU, Nasdaq Listing, Cannabis Banking, Financial Services, SEC Filing